This series explored federal policies that have increased the cost of cancer care for the Medicare Trust fund, private insurers and patients. By examining three policies (Medicare Modernization Act; 340B pricing for drugs; and Affordable Care Act), the articles show how the government triggered–and then sustained–the migration of cancer care from physician-owned centers to hospital-owned facilities. The articles also explain why care is much more expensive in hospital-owned facilities. The final installment examines whether the migration of cancer care to hospital facilities is good or bad for four stakeholder groups (patients, physicians, payers and hospitals.)
